Industry Research Reports

Home > Reports > Service & Software > Rheumatology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Rheumatology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Service & Software

Published Date: 2024-01-24

Pages: 112 Pages

Report ld: 2343150

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Rheumatology Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

MARKET SEGMENTATION

By Company

Takeda Pharmaceutical
Sanofi
Genentech
Novartis
Janssen Biotech
Amgen
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Disease Modifying Anti-rheumatic Drugs
Nonsteroidal Anti-inflammatory Drugs
Corticosteroids
Uric Acid Drugs
Others

Segment by Application

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Rheumatology Drugs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Rheumatology Drugs by region & country, by Type, and by Application.

The Rheumatology Drugs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatology Drugs.

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Rheumatology Drugs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Rheumatology Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Rheumatology Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Rheumatology Drugs Product Introduction

1.2 Global Rheumatology Drugs Market Size Forecast

1.3 Rheumatology Drugs Market Trends & Drivers

1.3.1 Rheumatology Drugs Industry Trends

1.3.2 Rheumatology Drugs Market Drivers & Opportunity

1.3.3 Rheumatology Drugs Market Challenges

1.3.4 Rheumatology Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Rheumatology Drugs Players Revenue Ranking (2023)

2.2 Global Rheumatology Drugs Revenue by Company (2019-2024)

2.3 Key Companies Rheumatology Drugs Manufacturing Base Distribution and Headquarters

2.4 Key Companies Rheumatology Drugs Product Offered

2.5 Key Companies Time to Begin Mass Production of Rheumatology Drugs

2.6 Rheumatology Drugs Market Competitive Analysis

2.6.1 Rheumatology Drugs Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Rheumatology Drugs Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Disease Modifying Anti-rheumatic Drugs

3.1.2 Nonsteroidal Anti-inflammatory Drugs

3.1.3 Corticosteroids

3.1.4 Uric Acid Drugs

3.1.5 Others

3.2 Global Rheumatology Drugs Sales Value by Type

3.2.1 Global Rheumatology Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Rheumatology Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Rheumatology Drugs Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital Pharmacy

4.1.2 Retail Pharmacy

4.1.3 Online Pharmacy

4.2 Global Rheumatology Drugs Sales Value by Application

4.2.1 Global Rheumatology Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Rheumatology Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Rheumatology Drugs Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Rheumatology Drugs Sales Value by Region

5.1.1 Global Rheumatology Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Rheumatology Drugs Sales Value by Region (2019-2024)

5.1.3 Global Rheumatology Drugs Sales Value by Region (2025-2030)

5.1.4 Global Rheumatology Drugs Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Rheumatology Drugs Sales Value, 2019-2030

5.2.2 North America Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Rheumatology Drugs Sales Value, 2019-2030

5.3.2 Europe Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Rheumatology Drugs Sales Value, 2019-2030

5.4.2 Asia Pacific Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Rheumatology Drugs Sales Value, 2019-2030

5.5.2 South America Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Rheumatology Drugs Sales Value, 2019-2030

5.6.2 Middle East & Africa Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Rheumatology Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Rheumatology Drugs Sales Value

6.3 United States

6.3.1 United States Rheumatology Drugs Sales Value, 2019-2030

6.3.2 United States Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Rheumatology Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Rheumatology Drugs Sales Value, 2019-2030

6.4.2 Europe Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Rheumatology Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Rheumatology Drugs Sales Value, 2019-2030

6.5.2 China Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Rheumatology Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Rheumatology Drugs Sales Value, 2019-2030

6.6.2 Japan Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Rheumatology Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Rheumatology Drugs Sales Value, 2019-2030

6.7.2 South Korea Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Rheumatology Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Rheumatology Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Rheumatology Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Rheumatology Drugs Sales Value, 2019-2030

6.9.2 India Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Rheumatology Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda Pharmaceutical

7.1.1 Takeda Pharmaceutical Profile

7.1.2 Takeda Pharmaceutical Main Business

7.1.3 Takeda Pharmaceutical Rheumatology Drugs Products, Services and Solutions

7.1.4 Takeda Pharmaceutical Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.1.5 Takeda Pharmaceutical Recent Developments

7.2 Sanofi

7.2.1 Sanofi Profile

7.2.2 Sanofi Main Business

7.2.3 Sanofi Rheumatology Drugs Products, Services and Solutions

7.2.4 Sanofi Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.2.5 Sanofi Recent Developments

7.3 Genentech

7.3.1 Genentech Profile

7.3.2 Genentech Main Business

7.3.3 Genentech Rheumatology Drugs Products, Services and Solutions

7.3.4 Genentech Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.3.5 Novartis Recent Developments

7.4 Novartis

7.4.1 Novartis Profile

7.4.2 Novartis Main Business

7.4.3 Novartis Rheumatology Drugs Products, Services and Solutions

7.4.4 Novartis Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.4.5 Novartis Recent Developments

7.5 Janssen Biotech

7.5.1 Janssen Biotech Profile

7.5.2 Janssen Biotech Main Business

7.5.3 Janssen Biotech Rheumatology Drugs Products, Services and Solutions

7.5.4 Janssen Biotech Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.5.5 Janssen Biotech Recent Developments

7.6 Amgen

7.6.1 Amgen Profile

7.6.2 Amgen Main Business

7.6.3 Amgen Rheumatology Drugs Products, Services and Solutions

7.6.4 Amgen Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.6.5 Amgen Recent Developments

7.7 AbbVie

7.7.1 AbbVie Profile

7.7.2 AbbVie Main Business

7.7.3 AbbVie Rheumatology Drugs Products, Services and Solutions

7.7.4 AbbVie Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.7.5 AbbVie Recent Developments

7.8 Pfizer

7.8.1 Pfizer Profile

7.8.2 Pfizer Main Business

7.8.3 Pfizer Rheumatology Drugs Products, Services and Solutions

7.8.4 Pfizer Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.8.5 Pfizer Recent Developments

7.9 Bristol-Myers Squibb Company

7.9.1 Bristol-Myers Squibb Company Profile

7.9.2 Bristol-Myers Squibb Company Main Business

7.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Products, Services and Solutions

7.9.4 Bristol-Myers Squibb Company Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.9.5 Bristol-Myers Squibb Company Recent Developments

7.10 Merck & Co.

7.10.1 Merck & Co. Profile

7.10.2 Merck & Co. Main Business

7.10.3 Merck & Co. Rheumatology Drugs Products, Services and Solutions

7.10.4 Merck & Co. Rheumatology Drugs Revenue (US$ Million) & (2019-2024)

7.10.5 Merck & Co. Recent Developments

8 Industry Chain Analysis

8.1 Rheumatology Drugs Industrial Chain

8.2 Rheumatology Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Rheumatology Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Rheumatology Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Rheumatology Drugs Market Trends

Table 2. Rheumatology Drugs Market Drivers & Opportunity

Table 3. Rheumatology Drugs Market Challenges

Table 4. Rheumatology Drugs Market Restraints

Table 5. Global Rheumatology Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Rheumatology Drugs Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Rheumatology Drugs Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Rheumatology Drugs Product Type

Table 9. Key Companies Time to Begin Mass Production of Rheumatology Drugs

Table 10. Global Rheumatology Drugs Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Rheumatology Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Rheumatology Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Rheumatology Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Rheumatology Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Rheumatology Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Rheumatology Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Rheumatology Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Rheumatology Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Rheumatology Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Rheumatology Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Rheumatology Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Rheumatology Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Rheumatology Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Rheumatology Drugs Sales Value by Region (2019-2024) & (%)

Table 27. Global Rheumatology Drugs Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Rheumatology Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Rheumatology Drugs Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Rheumatology Drugs Sales Value, (2025-2030) & (US$ Million)

Table 31. Takeda Pharmaceutical Basic Information List

Table 32. Takeda Pharmaceutical Description and Business Overview

Table 33. Takeda Pharmaceutical Rheumatology Drugs Products, Services and Solutions

Table 34. Revenue (US$ Million) in Rheumatology Drugs Business of Takeda Pharmaceutical (2019-2024)

Table 35. Takeda Pharmaceutical Recent Developments

Table 36. Sanofi Basic Information List

Table 37. Sanofi Description and Business Overview

Table 38. Sanofi Rheumatology Drugs Products, Services and Solutions

Table 39. Revenue (US$ Million) in Rheumatology Drugs Business of Sanofi (2019-2024)

Table 40. Sanofi Recent Developments

Table 41. Genentech Basic Information List

Table 42. Genentech Description and Business Overview

Table 43. Genentech Rheumatology Drugs Products, Services and Solutions

Table 44. Revenue (US$ Million) in Rheumatology Drugs Business of Genentech (2019-2024)

Table 45. Genentech Recent Developments

Table 46. Novartis Basic Information List

Table 47. Novartis Description and Business Overview

Table 48. Novartis Rheumatology Drugs Products, Services and Solutions

Table 49. Revenue (US$ Million) in Rheumatology Drugs Business of Novartis (2019-2024)

Table 50. Novartis Recent Developments

Table 51. Janssen Biotech Basic Information List

Table 52. Janssen Biotech Description and Business Overview

Table 53. Janssen Biotech Rheumatology Drugs Products, Services and Solutions

Table 54. Revenue (US$ Million) in Rheumatology Drugs Business of Janssen Biotech (2019-2024)

Table 55. Janssen Biotech Recent Developments

Table 56. Amgen Basic Information List

Table 57. Amgen Description and Business Overview

Table 58. Amgen Rheumatology Drugs Products, Services and Solutions

Table 59. Revenue (US$ Million) in Rheumatology Drugs Business of Amgen (2019-2024)

Table 60. Amgen Recent Developments

Table 61. AbbVie Basic Information List

Table 62. AbbVie Description and Business Overview

Table 63. AbbVie Rheumatology Drugs Products, Services and Solutions

Table 64. Revenue (US$ Million) in Rheumatology Drugs Business of AbbVie (2019-2024)

Table 65. AbbVie Recent Developments

Table 66. Pfizer Basic Information List

Table 67. Pfizer Description and Business Overview

Table 68. Pfizer Rheumatology Drugs Products, Services and Solutions

Table 69. Revenue (US$ Million) in Rheumatology Drugs Business of Pfizer (2019-2024)

Table 70. Pfizer Recent Developments

Table 71. Bristol-Myers Squibb Company Basic Information List

Table 72. Bristol-Myers Squibb Company Description and Business Overview

Table 73. Bristol-Myers Squibb Company Rheumatology Drugs Products, Services and Solutions

Table 74. Revenue (US$ Million) in Rheumatology Drugs Business of Bristol-Myers Squibb Company (2019-2024)

Table 75. Bristol-Myers Squibb Company Recent Developments

Table 76. Merck & Co. Basic Information List

Table 77. Merck & Co. Description and Business Overview

Table 78. Merck & Co. Rheumatology Drugs Products, Services and Solutions

Table 79. Revenue (US$ Million) in Rheumatology Drugs Business of Merck & Co. (2019-2024)

Table 80. Merck & Co. Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Rheumatology Drugs Downstream Customers

Table 84. Rheumatology Drugs Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

Table 88. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Rheumatology Drugs Product Picture

Figure 2. Global Rheumatology Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Rheumatology Drugs Report Years Considered

Figure 5. Global Rheumatology Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Rheumatology Drugs Revenue in 2023

Figure 7. Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Disease Modifying Anti-rheumatic Drugs Picture

Figure 9. Nonsteroidal Anti-inflammatory Drugs Picture

Figure 10. Corticosteroids Picture

Figure 11. Uric Acid Drugs Picture

Figure 12. Others Picture

Figure 13. Global Rheumatology Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Rheumatology Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 15. Product Picture of Hospital Pharmacy

Figure 16. Product Picture of Retail Pharmacy

Figure 17. Product Picture of Online Pharmacy

Figure 18. Global Rheumatology Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Rheumatology Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Rheumatology Drugs Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Rheumatology Drugs Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Rheumatology Drugs Sales Value (%), (2019-2030)

Figure 31. United States Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 37. China Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 39. China Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. India Rheumatology Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Rheumatology Drugs Sales Value by Type (%), 2023 VS 2030

Figure 51. India Rheumatology Drugs Sales Value by Application (%), 2023 VS 2030

Figure 52. Rheumatology Drugs Industrial Chain

Figure 53. Rheumatology Drugs Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Rheumatology Drugs market? zhanKai

The top companies in the global Rheumatology Drugs market are Takeda Pharmaceutical、Sanofi、Genentech.

Related Reports

Rheumatology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Rheumatology Drugs was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 107
USD 3950.00
(Single User License)
Global Rheumatology Drugs Market Research Report 2026
The global Rheumatology Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 104
USD 2900.00
(Single User License)
Global Rheumatology Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Rheumatology Drugs market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Global Rheumatology Drugs Market Research Report 2025
The global market for Rheumatology Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-27
Pages: 73
USD 2900.00
(Single User License)
Rheumatology Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Rheumatology Drugs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 89
USD 3950.00
(Single User License)
Global Rheumatology Drugs Market Insights, Forecast to 2030
Market Analysis and Insights: Global Rheumatology Drugs Market
Published Date: 2024-04-25
Pages: 106
USD 4900.00
(Single User License)
Global Rheumatology Drugs Market Research Report 2024
The global Rheumatology Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 86
USD 2900.00
(Single User License)

Rheumatology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Rheumatology Drugs was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 107
USD 3950.00 (Single User License)
Global Rheumatology Drugs Market Research Report 2026
The global Rheumatology Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 104
USD 2900.00 (Single User License)
Global Rheumatology Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Rheumatology Drugs market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)
Global Rheumatology Drugs Market Research Report 2025
The global market for Rheumatology Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-27
Pages: 73
USD 2900.00 (Single User License)
Rheumatology Drugs- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Rheumatology Drugs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 89
USD 3950.00 (Single User License)
Global Rheumatology Drugs Market Insights, Forecast to 2030
Market Analysis and Insights: Global Rheumatology Drugs Market
Published: 2024-04-25
Pages: 106
USD 4900.00 (Single User License)
Global Rheumatology Drugs Market Research Report 2024
The global Rheumatology Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 86
USD 2900.00 (Single User License)